Paclitaxel Cationic Liposome (CSPC Pharmaceutical)
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug NamePaclitaxel Cationic Liposome (CSPC Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPending
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A